Clinical trial
Study to Evaluate Reactogenicity and Immunogenicity of Revaccination With…
NCT00386698 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00386698 |
|---|---|
| Title | Study to Evaluate Reactogenicity and Immunogenicity of Revaccination With Adjuvanted Influenza Vaccine in Elderly Adults |
| Official title | Evaluate Reactogenicity & Immunogenicity of Adjuvanted Influenza Vaccine in Elderly Adults Previously Vaccinated With the Same Candidate Vaccine. Fluarix™ Administered in Young & Elderly Adults Will be Used as Reference |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Biological |
| Interventions | Fluarix, adjuvanted influenza vaccine |
| Enrollment | 200 |
| Start date | Oct 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Oct 11, 2006 |
| Last update posted | Oct 7, 2016 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: